Survey on Lymphedema After Sentinel Lymph Node Biopsy in People With Cervical or Vulvar Cancer

Memorial Sloan Kettering Cancer Center111 enrolled

Overview

The purpose of this study is to collect information that may identify people who are at risk of developing lower extremity lymphedema (LEL) after sentinel lymph node biopsy (SLN) during surgery for early-stage vulvar or cervical cancer, and to improve the quality and accuracy of the information that is given to people who have this procedure. Please note that, during this study, the researchers will collect information from a questionnaire completed by people who had SLN and LND+/- SLN during surgery for early-stage cervical or vulvar cancer. No form of treatment will be provided as part of the study, and no investigational tests or procedures will be performed.

Study Type

OBSERVATIONAL

Enrollment

111

Conditions

Cervical Cancer Vulvar Cancer

Interventions

QuestionnairesOTHER

A 13-item questionnaire specific to LEL, developed and validated by investigators at the Mayo Clinic. The EORTC QLQ-C30 is a 30-item questionnaire designed to assess the quality of life of cancer patients. The EORTC Quality of Life - Cervical Cancer Module.

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Presented to MSK with newly diagnosed early-stage cervical cancer of any histologic profile or early stage vulvar cancer of any histologic profile. °Early stage: Stage 1-2 * Underwent primary surgery at our institution between January 2006 and January 2022. * Alive at the time of study activation * English comprehension * Capable of providing informed consent Exclusion Criteria: * Had documented macroscopic evidence of metastatic disease at the time of initial diagnosis

Outcomes

Primary Outcomes

prevalence of patient-reported lower extremity lymphedema

Prevalence will be measured using the 13-item questionnaire as reported by the patient.

Time frame: 1 year